News

The Royal Society Interface Focus, CompBioMed Conference 2019 Themed Issue

We are delighted to announce that part 1 of a two-part themed issue resulting from papers originally submitted to the CompBioMed Conference 2019 has now been published with many articles available for all to read as open source articles, The Royal Society Interface Focus. Part 2 of the themed issue, ...
Read More

The nUCLeus Hub: Scalable training in computational biomedicine

How can we provide sustainable and affordable HPC training to the next generation of life sciences graduates and future physicians during a global pandemic? This is the unforeseen question that instigated an ambitious collaboration between CompBioMed core partner University College London and associate partner Alces Flight at the start of ...
Read More

CompBioMed Associate Partners predicting the impact of closing your local shop on the spread of covid-19

Researchers from the Brunel University have developed a simulation tool that models the viral spread at the sub-national level, the “Flu And Corona virus Simulator” (FACS). FACS incorporates geospatial data from open sources to single building resolution within small predefined regions. Using FACS, the researchers have modelled the spread of ...
Read More

CompBioMed featured on Futuris programme of EuroNews

We’d like to announce that our work has been featured in the EuroNews programming within the Futuris section looking at the latest news about the leading scientific and technological research projects in Europe. Project Coordinator, Peter Coveney as well as Andrea Townsend-Nicholson were interviewed from UCL, and Dieter Kranzlmüller and ...
Read More

PhD studentship in Virtual Human Cardiovascular Modelling & Simulation

The Centre for Computational Science (CCS) of University College London (UCL) is offering a fully-funded studentship to a highly motivated candidate to start in September 2020. The studentship will cover tuition fees at UK/EU rate plus a maintenance stipend of £17,285 (tax free) per annum for three years. The post-holder ...
Read More

The World’s Fastest Computer to Join Fight Against COVID-19

In our previous blog posts we have highlighted in the work of the Argonne National Laboratory (ANL) and Barcelona Supercomputing Center (BSC) that High Performance Computing (HPC) resources are an invaluable research tool. Much like their counterparts and colleagues around the world, Japan’s top scientists are now refocusing and accelerating ...
Read More

AI-driven integrative biology for accelerating therapeutic drug discoveries to treat SARS-CoV-2

CompBioMed partners and academics from other research facilities are carrying out research to address the fundamental biological mechanisms of both the SARS-CoV-2 novel corona virus and the COVID-19 disease it causes. The ongoing research also includes an attempt to target the entire viral proteome (entire complement of proteins that is ...
Read More

Cardiotoxicity: Supercomputer-based in silico studies by CompBioMed Core Partners aiming to make COVID-19 treatment safer for the heart

The use of certain drugs can disturb the rhythm at which hearts beat.  This disruption can have toxic effects on the heart, which are particularly dangerous for those with underlying medical conditions.  Two drugs which are known to have proarrhythmic effects are the antimalarial drugs azithromycin and hydroxychloroquine. Azithromycin and ...
Read More

3-year PhD studentship in the simulation of chaotic systems

The Centre for Computational Science (CCS) of University College London (UCL) in collaboration with CBK Sci Con are offering a fully-funded studentship to a highly motivated candidate to start in September 2020. The studentship will cover tuition fees at UK/EU rate plus a maintenance stipend of £17,285 (tax free) per ...
Read More

Repurposing Existing Drugs in the Fight Against COVID-19

The use of existing pharmaceutical to treat COVID-19 has several potential benefits over the development of new drugs from the group up, not least that much shorter clinical trials would be needed and production on industrial scales has already been realised in many cases. Andrew Potterton, a PhD student at ...
Read More